US 11001610
Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof
granted A61KA61K38/00A61K47/60
Quick answer
US patent 11001610 (Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof) held by Apellis Pharmaceuticals, Inc. expires Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Apellis Pharmaceuticals, Inc.
- Grant date
- Tue May 11 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K38/00, A61K47/60, A61K47/643, A61P